These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6851167)

  • 41. Active-site-directed inactivation of human liver alpha-L-fucosidase by conduritol C trans-epoxide.
    White WJ; Schray KJ; Legler G; Alhadeff JA
    Biochim Biophys Acta; 1986 Sep; 873(2):198-203. PubMed ID: 3756175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary lysosomal hydrolases in mucolipidosis II and mucolipidosis III.
    Kress BC; Miller AL
    Biochem J; 1979 Feb; 177(2):409-15. PubMed ID: 35150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of alpha-L-fucosidase by derivatives of deoxyfuconojirimycin and deoxymannojirimycin.
    Winchester B; Barker C; Baines S; Jacob GS; Namgoong SK; Fleet G
    Biochem J; 1990 Jan; 265(1):277-82. PubMed ID: 2137330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. pH-dependent association-dissociation of high and low activity plasma alpha-L-fucosidase.
    Willems PJ; Romeo E; Den Tandt WR; Van Elsen AF; Leroy JG
    Hum Genet; 1981; 59(2):115-8. PubMed ID: 7327570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and characterization of human seminal plasma alpha-L-fucosidase.
    Khunsook S; Alhadeff JA; Bean BS
    Mol Hum Reprod; 2002 Mar; 8(3):221-7. PubMed ID: 11870229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Alpha-L-fucosidase of normal and pathological blood cells].
    Percheron F; Bernard M; Foglietti MJ
    Bull Acad Natl Med; 1991 Feb; 175(2):205-14; discussion 215. PubMed ID: 1863862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. alpha-L-Fucosidase from rat liver lysosomes.
    Opheim DJ; Touster O
    Methods Enzymol; 1978; 50():505-10. PubMed ID: 26840
    [No Abstract]   [Full Text] [Related]  

  • 48. [The BM test and lysosomal enzyme in the meconium in neonatal screening of cystic fibrosis].
    Marchi AG; Castelpietra L; Mangiarotti MA; Cigui I; Uxa F; Pecile V; Nordio S
    Minerva Pediatr; 1981 Jul; 33(13):641-6. PubMed ID: 6267441
    [No Abstract]   [Full Text] [Related]  

  • 49. Measurement of alpha-glucosidase activity in serum from patients with cystic fibrosis or pancreatitis.
    Porter WH; Jennings CD; Wilson HD
    Clin Chem; 1986 Apr; 32(4):652-6. PubMed ID: 3513992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. alpha-L-fucosidase from aspergillus niger: demonstration of a novel alpha-L-(1----6)-fucosidase acting on glycopeptides.
    Yazawa S; Madiyalakan R; Chawda RP; Matta KL
    Biochem Biophys Res Commun; 1986 Apr; 136(2):563-9. PubMed ID: 2423086
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycosidases in serum of cystic fibrosis patients.
    Casola L; Di Matteo G; Romano M; Rutigliano B; Mastella G
    Clin Chim Acta; 1979 May; 94(1):83-8. PubMed ID: 110502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isoform, kinetic and immunochemical characterization of rodent liver alpha-L-fucosidases.
    Johnson SW; Alhadeff JA
    Comp Biochem Physiol B; 1990; 97(4):713-7. PubMed ID: 2085955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are measurements of urine enzymes useful during aminoglycoside therapy?
    Reed MD; Vermeulen MW; Stern RC; Cheng PW; Powell SH; Boat TF
    Pediatr Res; 1981 Sep; 15(9):1234-9. PubMed ID: 6793992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunocytochemical localization and biochemical characterization of a novel plasma membrane-associated, neutral pH optimum alpha-L-fucosidase from rat testis and epididymal spermatozoa.
    Avilés M; Abascal I; Martínez-Menárguez JA; Castells MT; Skalaban SR; Ballesta J; Alhadeff JA
    Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):821-31. PubMed ID: 8836125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variation in alpha-L-fucosidase properties among 28 inbred mouse strains: six strains have high enzyme activity and heat-stabile enzyme with a variant pH-activity curve; twenty-two strains have low activity and heat-labile enzyme.
    Johnson WG; Hong JL
    Biochem Genet; 1986 Jun; 24(5-6):469-83. PubMed ID: 3741369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Purification and characterization of I-cell disease alpha-L-fucosidase.
    Kress BC; Freeze HH; Herd JK; Alhadeff JA; Miller AL
    J Biol Chem; 1980 Feb; 255(3):955-61. PubMed ID: 7356669
    [No Abstract]   [Full Text] [Related]  

  • 57. Antibody-affinity purification of novel alpha-L-fucosidase from mouse liver.
    Laury-Kleintop LD; Damjanov I; Alhadeff JA
    Biochem J; 1987 Jul; 245(2):589-93. PubMed ID: 3663178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Properties of two forms of alpha-L-fucosidase isolated from normal human sera with low and high enzymatic activity.
    Bernard M; Foglietti MJ; Percheron F
    Clin Chim Acta; 1981 Oct; 116(1):91-9. PubMed ID: 7318178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction of ovalbumin and its asparaginyl-carbohydrate fractions with concanavalin A.
    Shepherd V; Montgomery R
    Biochim Biophys Acta; 1978 Aug; 535(2):356-69. PubMed ID: 678557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The effect of glycolipids [correction of glycoproteins] on the oligomeric structure and catalytic activity of alpha-L-fucosidase from human kidneys].
    Pshezhetskiĭ AV; Beĭer EM; Vinogradova MV; Vidershaĭn GIa
    Biokhimiia; 1993 Jun; 58(6):879-90. PubMed ID: 8364111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.